Summary of public comments received on the draft screening assessment for sodium cyclamate and cyclohexylamine

Comments on the draft Screening Assessment for Sodium Cyclamate and Cyclohexylamine, assessed under the Chemicals Management Plan (CMP), were submitted by an individual and a stakeholder association.

Summarized public comments and responses are provided below, organized by topic:

Consultations and stakeholder engagement

Summarized comment Summarized response
Stakeholders remain available should further input be required in the finalization of the assessment.


New information and data

Summarized comment Summarized response
An additional research study for sodium cyclamate was provided for consideration in the screening assessment. Additional information submitted was considered. However, no changes were made to the screening assessment in response to this submission since the information did not result in a change to the human health risk characterization of sodium cyclamate or cyclohexylamine.
Report a problem or mistake on this page
Please select all that apply:

Thank you for your help!

You will not receive a reply. For enquiries, contact us.

Date modified: